BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 33976001)

  • 1. Indian contribution toward biomedical research and development in COVID-19: A systematic review.
    Kaur H; Kaur M; Bhattacharyya A; Prajapat M; Thota P; Sarma P; Kumar S; Kaur G; Sharma S; Prakash A; Saifuddin PK; Medhi B
    Indian J Pharmacol; 2021; 53(1):63-72. PubMed ID: 33976001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting COVID-19 with Artificial Intelligence.
    Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
    Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
    Majumder J; Minko T
    AAPS J; 2021 Jan; 23(1):14. PubMed ID: 33400058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-line treatments and clinical initiatives to fight against COVID-19 outbreak.
    Agrawal M; Saraf S; Saraf S; Murty US; Kurundkar SB; Roy D; Joshi P; Sable D; Choudhary YK; Kesharwani P; Alexander A
    Respir Med; 2022 Jan; 191():106192. PubMed ID: 33199136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A call to arms.
    Service RF
    Science; 2021 Mar; 371(6534):1092-1095. PubMed ID: 33707248
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development.
    Sreepadmanabh M; Sahu AK; Chande A
    J Biosci; 2020; 45(1):. PubMed ID: 33410425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review.
    Kröker A; Tirzīte M
    Respir Res; 2021 Nov; 22(1):304. PubMed ID: 34838020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primed for global coronavirus pandemic: Emerging research and clinical outcome.
    Ahamad S; Branch S; Harrelson S; Hussain MK; Saquib M; Khan S
    Eur J Med Chem; 2021 Jan; 209():112862. PubMed ID: 33070079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to watch in 2021.
    Kaplon H; Reichert JM
    MAbs; 2021; 13(1):1860476. PubMed ID: 33459118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment.
    Martinez MA
    Front Immunol; 2021; 12():635371. PubMed ID: 33777024
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 in the Age of Artificial Intelligence: A Comprehensive Review.
    Rasheed J; Jamil A; Hameed AA; Al-Turjman F; Rasheed A
    Interdiscip Sci; 2021 Jun; 13(2):153-175. PubMed ID: 33886097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
    Colson P; La Scola B; Lagier JC; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106238. PubMed ID: 33408030
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
    Million M; Roussel Y; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106240. PubMed ID: 33408019
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
    Bhattacharyya P; Das S; Aich S; Sarkar J
    Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates.
    Serafim MSM; Gertrudes JC; Costa DMA; Oliveira PR; Maltarollo VG; Honorio KM
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33624754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.
    Floresta G; Zagni C; Gentile D; Patamia V; Rescifina A
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges.
    Chang R; Sun WZ
    Drug Discov Today; 2020 Oct; 25(10):1786-1792. PubMed ID: 32629169
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Brown RE; Tahseen D
    Ann Clin Lab Sci; 2020 Nov; 50(6):837-841. PubMed ID: 33334802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief review on repurposed drugs and vaccines for possible treatment of COVID-19.
    De P; Chakraborty I; Karna B; Mazumder N
    Eur J Pharmacol; 2021 May; 898():173977. PubMed ID: 33639193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.